Selective Immunosuppressants
A DrugBank category of 52 drugs. 47 of them are approved.
- ATC classification
- Drugs
- Abatacept
- Abetimus
- Alefacept
- Alemtuzumab
- Anifrolumab
- Antilymphocyte immunoglobulin (horse)
- Antithymocyte immunoglobulin (rabbit)
- Apremilast
- Atacicept
- Avacopan
- Baricitinib
- Begelomab
- Belatacept
- Belimumab
- Belumosudil
- Brepocitinib
- Cladribine
- Deucravacitinib
- Eculizumab
- Efalizumab
- Efgartigimod alfa
- Emapalumab
- Everolimus
- Filgotinib
- Fingolimod
What you can answer from here — as of August 24, 2016
Which targets do Selective Immunosuppressants share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account